BioXcel Therapeutics, Inc. (BTAI) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -11.81M | -14.21M | -18.79M | -12.57M | -12.04M | -14.81M | -16.34M | -23.17M | -17.71M | -26.86M | -37.58M | -38.21M | -52.35M | -38.64M | -31.19M | -33.1M | -32.41M | -19.93M | -20.2M | -22.38M |
| Operating CF Margin % | -5732.52% | -5550.78% | -19170.41% | -10479.17% | -7168.45% | -4046.17% | -7634.58% | -2099.09% | -3042.27% | -7144.41% | -11021.7% | -8360.18% | -25414.08% | -16234.87% | -22763.5% | - | - | - | - | - |
| Operating CF Growth % | 1.94% | 4.04% | -14.99% | 45.74% | 31.98% | 44.87% | 56.53% | 39.34% | 66.18% | 30.48% | -20.52% | -15.42% | -61.52% | -93.85% | -54.39% | -47.9% | -65.04% | 1.68% | -5.75% | -51.03% |
| Net Income | -12.69M | -12.54M | -30.91M | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M | -52.8M | -54.81M | -41.8M | -37.67M | -31.47M | -26.13M | -26.81M | -27.62M |
| Depreciation & Amortization | 58K | 74K | 75K | 75K | 76K | 77K | 77K | 77K | 78K | 78K | 79K | 153K | 80K | 81K | 85K | 84K | 77K | 76K | 77K | 79K |
| Stock-Based Compensation | 435K | 450K | 581K | 1.56M | 180K | 0 | 1.86M | 1.06M | 3.43M | 3.6M | 4.01M | 0 | 4.88M | 4.55M | 0 | 4.48M | 3.83M | 2.24M | 4.88M | 6.77M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.88M | 0 | 0 |
| Other Non-Cash Items | -961K | -1.26M | 13.06M | 2.58M | -3.46M | -472K | -3.31M | -10.59M | 1.3M | 1.13M | 862K | 6.41M | 1.03M | 1.2M | 5.04M | 321K | 0 | -3.88M | 46K | 0 |
| Working Capital Changes | 1.35M | -928K | -1.6M | 2.4M | -1.58M | -3.56M | -1.32M | -5.42M | 4.27M | -9.41M | 7.95M | 8.75M | -5.55M | 10.34M | 5.5M | -320K | -4.84M | 3.88M | 1.6M | -1.61M |
| Change in Receivables | 17K | -233K | 17K | -17K | 131K | -128K | 809K | -434K | -307K | 664K | -304K | -148K | -35K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 222K | -263K | 47K | 136K | 37K | 846K | 1.16M | -241K | -448K | 27K | -93K | 27K | 33K | -577K | -13K | -713K | -682K | 0 | 0 | 0 |
| Change in Payables | 2.21M | 8.01M | -1.08M | 2.31M | -2.27M | -3.33M | -1.66M | -4.16M | 4.83M | -12.32M | 7.25M | 6.5M | -4.65M | 9.23M | 480K | 3.99M | -676K | 2.04M | 2.25M | 156K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20K | 0 | 0 | 0 | -19K | -120K | -12K | -17K | -100K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20K | 0 | 0 | 0 | -19K | -120K | -12K | -17K | -100K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 4.38% | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 232K | 5.65M | 37.53M | 137K | 13.2M | 4.28M | 454K | 5.3M | 26.63M | 2.12M | 0 | 250K | 24.15M | 50K | 30.05M | 66.14M | 0 | 0 | 71K | 101.52M |
| Debt Issued (Net) | -8.11M | 0 | 0 | 0 | 0 | -2.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30M | 65.95M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 8.34M | 5.65M | 37.55M | 140K | 14.01M | 6.82M | 468K | 5.48M | 26.74M | 2.38M | 0 | 250K | 24.66M | 50K | 48K | 185K | 0 | 0 | -34K | 101.03M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -16K | -3K | -804K | -46K | -14K | -172K | -117K | -252K | 0 | 0 | -508K | 0 | 0 | 0 | 0 | 0 | 105K | 497K |
| Net Change in Cash | -11.58M | -8.56M | 18.75M | -12.44M | 1.16M | -10.53M | -15.88M | -17.87M | 8.92M | -24.74M | -37.58M | -37.98M | -28.2M | -38.59M | -1.14M | 33.02M | -32.53M | -19.94M | -20.14M | 79.04M |
| Free Cash Flow | -11.81M | -14.21M | -18.79M | -12.57M | -12.04M | -14.81M | -16.34M | -23.17M | -17.71M | -26.86M | -37.58M | -38.23M | -52.35M | -38.64M | -31.19M | -33.12M | -32.53M | -19.94M | -20.22M | -22.48M |
| FCF Margin % | -5732.52% | -5550.78% | -19170.41% | -10479.17% | -7168.45% | -4046.17% | -7634.58% | -2099.09% | -3042.27% | -7144.41% | -11021.7% | -8364.55% | -25414.08% | -16234.87% | -22763.5% | - | - | - | - | - |
| FCF Growth % | 1.94% | 4.04% | -14.99% | 45.74% | 31.98% | 44.87% | 56.53% | 39.38% | 66.18% | 30.48% | -20.52% | -15.41% | -60.92% | -93.74% | -54.26% | -47.33% | -63.02% | 2.91% | -5.87% | -51.34% |
| FCF per Share | -0.97 | -1.16 | -1.32 | -1.60 | -2.49 | -4.87 | -6.17 | -9.21 | -9.18 | -14.59 | -20.55 | -20.96 | -29.27 | -22.03 | -17.81 | -18.93 | -18.60 | -11.40 | -11.56 | -14.41 |
| FCF Conversion (FCF/Net Income) | 0.93x | 1.13x | 0.61x | 0.66x | 1.66x | 1.36x | 1.20x | 2.79x | 0.66x | 1.21x | 0.74x | 0.71x | 0.99x | 0.70x | 0.75x | 0.88x | 1.03x | 0.76x | 0.75x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 596K | 0 | 0 | 0 | 0 | 0 | 0 | 23K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |